Skip to main navigation Skip to search Skip to main content

Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat

Research output: Contribution to journalArticleResearchpeer-review

Abstract

This study has evaluated the effects of the angiotensin converting enzyme inhibitor Enalapril on glomerular ultrastructure and albuminuria in normotensive and hypertensive diabetic rats. Streptozotocin-diabetes was induced in Wistar Kyoto and spontaneously hypertensive rats. Enalapril was administered in drinking water in diabetic normotensive, control hypertensive and diabetic hypertensive rats. Enalapril therapy prevented an increase in glomerular basement membrane thickness in diabetic normotensive, control hypertensive and diabetic hypertensive rats without any significant effect on fractional mesangial volume. Enalapril decreased albuminuria in diabetic normotensive, control hypertensive and diabetic hypertensive rats. Thus, enalapril retards the development of glomerular basement membrane thickening and albuminuria in the rat, in the presence or absence of hypertension.

Original languageEnglish
Pages (from-to)326-328
Number of pages3
JournalDiabetologia
Volume32
Issue number5
DOIs
Publication statusPublished - 1 May 1989
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • albuminuria
  • Diabetes
  • enalapril
  • hypertension
  • nephropathy

Cite this